-
Active Stocks to Watch : Zynga Inc (NASDAQ:ZNGA), GlaxoSmithKline plc (NYSE:GSK), Orient Paper(NYSEMKT:ONP), The Bank of Kentucky Financial (NASDAQ:BKYF), ARC
Zynga Inc (NASDAQ:ZNGA) announced via its blog Thursday that it would be re-releasing its old poker client, to be called Zynga Poker Classic. The social gaming giant launched a revamped version of its popular poker product in September. The platform overhaul replaced the cartoonish look-and-feel with more realistic graphics and player avatars. Zynga Inc (NASDAQ:ZNGA)…
-
Market Movers: United Continental Holdings(NYSE:UAL), GlaxoSmithKline plc (NYSE:GSK), Mueller Water Products(NYSE:MWA), Tronox Limited (NYSE:TROX), Johnson & Johnson (NYSE:JNJ)
United Continental Holdings, Inc. (NYSE:UAL) reported that it had generated revenues of $10.6 billion during the quarter, in line with what analysts had expected. The revenues for the airline increased 3.3% YoY. Passenger revenues rose 4.4%, while revenue generated from cargo operations increased 19.1% YoY. United Continental Holdings, Inc. (NYSE:UAL) in last trading activity moved…
-
Stock Upgrades & Downgrades: Alcatel Lucent (NYSE:ALU), Luxottica Group (NYSE:LUX), Dow Chemical Company (NYSE:DOW), Alibaba Group, AbbVie Inc. (NYSE:ABBV), GlaxoSmithKline, MDCO
Alcatel Lucent SA (ADR) (NYSE:ALU) stock upgraded to Hold from Underperform at Jefferies. Alcatel Lucent SA (ADR) (NYSE:ALU) in last trading activity advanced 3.21% to close at $2.57. Company weekly performance is 8.90% while its quarterly performance stands at -31.83%. Alcatel Lucent SA (ADR) (NYSE:ALU) is -45.09% away from its 52 week high. Luxottica Group…
-
Investor’s Choice: Nokia Corporation (ADR) (NYSE:NOK), GlaxoSmithKline plc (NYSE:GSK), Pacific Premier Bancorp Inc. (NASDAQ:PPBI), Himax Technologies(NASDAQ:HIMX), Skechers (NYSE:SKX)
Shares of Nokia Corporation (ADR) (NYSE:NOK) have received an average rating of “Hold” from the twenty-seven ratings firms that are presently covering the company, Stock Ratings News reports. Two analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and fourteen have issued a buy recommendation on the company. The…
-
Biotech Movers – VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), GlaxoSmithKline plc (ADR) (NYSE:GSK)
VIVUS, Inc. (NASDAQ:VVUS) dropped 5.32%, continuing to move lower after the company and Auxilium Pharmaceuticals, Inc. (AUXL) declared that the U.S. Food and Drug Administration (FDA) has accepted a supplemental application that proposes to revise the STENDRA(TM) (avanafil) prescribing information with efficacy and safety information from Study TA-501, entitled “A Randomized, Double-Blind, Placebo-Controlled Evaluation of…
-
GlaxoSmithKline plc (LON:GSK) has To Sell Its Thrombosis Brands, Indian Court Has Favored Nokia Corporation (ADR) (NYSE:NOK) In Tax Dispute
On Monday GlaxoSmithKline plc (LON:GSK) has said that it is going to sell its thrombosis brands along with the Notre-Dame de Bondeville developing location, to Aspen Pharmacare Holdings Ltd. for $1.13 billion or 0.7 billion pounds. The pharmaceutical giant has made its attempt to focus on the sale of the brands including Fraxiparine(R) and Arixtra(R),…